Liver histology

WikiDoc Resources for Liver histology

Articles

Most recent articles on Liver histology

Most cited articles on Liver histology

Review articles on Liver histology

Articles on Liver histology in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Liver histology

Images of Liver histology

Photos of Liver histology

Podcasts & MP3s on Liver histology

Videos on Liver histology

Evidence Based Medicine

Cochrane Collaboration on Liver histology

Bandolier on Liver histology

TRIP on Liver histology

Clinical Trials

Ongoing Trials on Liver histology at Clinical Trials.gov

Trial results on Liver histology

Clinical Trials on Liver histology at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Liver histology

NICE Guidance on Liver histology

NHS PRODIGY Guidance

FDA on Liver histology

CDC on Liver histology

Books

Books on Liver histology

News

Liver histology in the news

Be alerted to news on Liver histology

News trends on Liver histology

Commentary

Blogs on Liver histology

Definitions

Definitions of Liver histology

Patient Resources / Community

Patient resources on Liver histology

Discussion groups on Liver histology

Patient Handouts on Liver histology

Directions to Hospitals Treating Liver histology

Risk calculators and risk factors for Liver histology

Healthcare Provider Resources

Symptoms of Liver histology

Causes & Risk Factors for Liver histology

Diagnostic studies for Liver histology

Treatment of Liver histology

Continuing Medical Education (CME)

CME Programs on Liver histology

International

Liver histology en Espanol

Liver histology en Francais

Business

Liver histology in the Marketplace

Patents on Liver histology

Experimental / Informatics

List of terms related to Liver histology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:  Your Name

Synonyms and keywords: Synonym 1; Synonym 2; Synonym 3

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

## Overview

[edit | edit source]

## Historical Perspective

[edit | edit source]

* [Disease name] was first discovered by [scientist name], a [nationality + occupation], in [year] during/following [event].
* In [year], [gene] mutations were first identified in the pathogenesis of [disease name].
* In [year], the first [discovery] was developed by [scientist] to treat/diagnose [disease name].

## Classification

[edit | edit source]

* [Disease name] may be classified according to [classification method] into [number] subtypes/groups:

* [group1]
* [group2]
* [group3]

* Other variants of [disease name] include [disease subtype 1], [disease subtype 2], and [disease subtype 3].

## Pathophysiology

[edit | edit source]

* The pathogenesis of [disease name] is characterized by [feature1], [feature2], and [feature3].
* The [gene name] gene/Mutation in [gene name] has been associated with the development of [disease name], involving the [molecular pathway] pathway.
* On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].
* On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of [disease name].

## Causes

[edit | edit source]

* [Disease name] may be caused by either [cause1], [cause2], or [cause3].
* [Disease name] is caused by a mutation in the [gene1], [gene2], or [gene3] gene[s].
* There are no established causes for [disease name].

## Differentiating [disease name] from other Diseases

[edit | edit source]

* [Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as:

* [Differential dx1]
* [Differential dx2]
* [Differential dx3]

## Epidemiology and Demographics

[edit | edit source]

* The prevalence of [disease name] is approximately [number or range] per 100,000 individuals worldwide.
* In [year], the incidence of [disease name] was estimated to be [number or range] cases per 100,000 individuals in [location].

### Age

[edit | edit source]

* Patients of all age groups may develop [disease name].

* [Disease name] is more commonly observed among patients aged [age range] years old.
* [Disease name] is more commonly observed among [elderly patients/young patients/children].

### Gender

[edit | edit source]

* [Disease name] affects men and women equally.

* [Gender 1] are more commonly affected with [disease name] than [gender 2].
* The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.

### Race

[edit | edit source]

* There is no racial predilection for [disease name].

* [Disease name] usually affects individuals of the [race 1] race.
* [Race 2] individuals are less likely to develop [disease name].

## Risk Factors

[edit | edit source]

* Common risk factors in the development of [disease name] are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

## Natural History, Complications and Prognosis

[edit | edit source]

* The majority of patients with [disease name] remain asymptomatic for [duration/years].
* Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
* If left untreated, [#%] of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
* Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
* Prognosis is generally [excellent/good/poor], and the [1/5/10­year mortality/survival rate] of patients with [disease name] is approximately [#%].

## Diagnosis

[edit | edit source]

### Diagnostic Criteria

[edit | edit source]

* The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met:

* [criterion 1]
* [criterion 2]
* [criterion 3]
* [criterion 4]

### Symptoms

[edit | edit source]

* [Disease name] is usually asymptomatic.
* Symptoms of [disease name] may include the following:

* [symptom 1]
* [symptom 2]
* [symptom 3]
* [symptom 4]
* [symptom 5]
* [symptom 6]

### Physical Examination

[edit | edit source]

* Patients with [disease name] usually appear [general appearance].
* Physical examination may be remarkable for:

* [finding 1]
* [finding 2]
* [finding 3]
* [finding 4]
* [finding 5]
* [finding 6]

### Laboratory Findings

[edit | edit source]

* There are no specific laboratory findings associated with [disease name].

* A [positive/negative] [test name] is diagnostic of [disease name].
* An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of [disease name].
* Other laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

### Imaging Findings

[edit | edit source]

* There are no [imaging study] findings associated with [disease name].

* [Imaging study 1] is the imaging modality of choice for [disease name].
* On [imaging study 1], [disease name] is characterized by [finding 1], [finding 2], and [finding 3].
* [Imaging study 2] may demonstrate [finding 1], [finding 2], and [finding 3].

### Other Diagnostic Studies

[edit | edit source]

* [Disease name] may also be diagnosed using [diagnostic study name].
* Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].

## Treatment

[edit | edit source]

### Medical Therapy

[edit | edit source]

* There is no treatment for [disease name]; the mainstay of therapy is supportive care.

* The mainstay of therapy for [disease name] is [medical therapy 1] and [medical therapy 2].
* [Medical therapy 1] acts by [mechanism of action 1].
* Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].

### Surgery

[edit | edit source]

* Surgery is the mainstay of therapy for [disease name].
* [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of [disease name].
* [Surgical procedure] can only be performed for patients with [disease stage] [disease name].

### Prevention

[edit | edit source]

* There are no primary preventive measures available for [disease name].

* Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].

* Once diagnosed and successfully treated, patients with [disease name] are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].

## References

[edit | edit source]

Template:WS Template:WH